Filed before 2025Filed 17 November 2022
Switch Therapeutics Inc. has sold $23.3M so far
Switch Therapeutics Inc., a company based in South San Francisco, CA, has sold $23.3M so far in its equity round, according to a filing dated 17 November 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 17 November 2022
- First filed
- 5 October 2022
- Round
- Equity round (amended filing)
- Amount sold
- $23.3M
- Offering size
- $36M
- Investors so far
- 15
- Based in
- South San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 74% of the 1,764 tracked raises with an amount filed in 2022.
Switch Therapeutics Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Nov 2022 | Amended filing | $23.3M | This raise |
| 5 Oct 2022 | New filing | $19.9M | This raise |
More with Upfront Secondary on the board
- Daytona Platforms Inc.$48.3M
- Landline Co$1.43M
- Cellular Longevity, Inc.$22.2M
- Playbook Digital Inc.Undisclosed
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.